RNA-Loaded Dendritic Cell Cancer Vaccine
The purpose of this trial is to examine the safety, feasibility, immunological response, and clinical antitumor activity of administering a dendritic cell vaccine to patients with metastatic renal cell carcinoma.
Renal Cell Carcinoma
BIOLOGICAL: MB-002
To examine the safety of multiple administrations of MB-002 in patients with newly diagnosed, metastatic renal cell carcinoma., From registration until disease progression or withdrawal from study|To measure clinical antitumor activity including objective tumor response and an estimate of time to tumor progression (or progression-free interval)., From registration until disease progression or withdrawal from study
The purpose of this trial is to examine the safety, feasibility, immunological response, and clinical antitumor activity of administering a dendritic cell vaccine to patients with metastatic renal cell carcinoma.